Return to the ObGyn Home Page

Anonymous Oocyte (Egg) Donation Program

ESTIMATED non-binding fees for IVF/ICSI are for information purposes only and are subject to change without notice. A $3,000.00 prepayment is required before you start the program. This will create a credit balance on your billing statement, and charges will be applied as services are rendered. Any portion remaining after completion of this program will be promptly refunded. This prepayment does not cover the cost of medications.
Please contact Mary Lea at (601) 984-5310 regarding your prepayment and possible filing of your insurance for reimbursement.

We emphasize that these estimates are based on an average cycle. Your cycle could be longer and therefore more expensive. Also, if your physician determines that intracytoplasmic sperm injection (ICSI) is needed, an additional charge of $1,250.00 is incurred when we complete this extra therapy.

Medications* (e.g. Follistim, Pergonal, Humegon, Fertinex and Lupron) are charged separately by your pharmacist when your prescription is filled. Thus, this estimated cost may vary by your pharmacist or treatment requirements.

Oocyte donation is a treatment available for couples who cannot become pregnant during standard in vitro fertilization (IVF) using the wife’s eggs.  Examples include:

  • patients with ovarian failure (early menopause),
  • repeated IVF failures,
  • potentially transmissible maternal genetic disorders, or
  • advanced maternal age
During the egg donation procedure, eggs obtained from a donor are fertilized using the recipient's husband's sperm and the resulting embryos are placed into the recipient's uterus. Currently, approximately 40% of couples who complete a single course of this therapy will establish a pregnancy. This pregnancy rate represents one of the highest pregnancy rates that results from assisted reproductive technologies.

Egg donors in this program are anonymous, will be compensated for their inconvenience, and voluntarily agree to participate. There is no contact between the donor and the recipient. The identities of each party are held in strictest confidence. All potential donors undergo a thorough screen consisting of:

  • a medical and genetic history,
  • a physical examination,
  • psychological screening, and
  • testing for sexually transmitted diseases including HIV
  • Additionally, egg donors will be subject to random screening for illicit drug use
Non-identifying demographic information that is available to assist in the selection of a prospective donor include:
  • height,
  • weight,
  • eye color,
  • hair color,
  • education,
  • occupation,
  • blood type, and
  • Rh factor
  • Anonymous donors will be > 21 and < 34 years of age when donating
Recipients for egg donation undergo a screening process similar to that for egg donors. This consists of a history and physical examination, assessment of the uterine cavity (hysterosalpingogram or ultrasound), psychological screening for the recipient and partner and testing for sexually transmitted diseases including HIV. Currently, our cut-off for recipients is 50 years of age.

Treatment Guidelines
Preparation for egg donation requires treatment with medications designed to stimulate the development of as many eggs as possible within the ovaries. This widely used treatment protocol is identical to that used for patients undergoing IVF. This treatment can be divided into the following steps:
Ovarian Suppression The initial step of the stimulation process involves administration of a medication, called Lupron that produces a temporary menopausal state. This medication is typically started on day 21 of your menstrual cycle and continued for approximately two weeks prior to stimulation. We use this medication in an attempt to prevent a premature release of eggs from the ovary and to synchronize egg development. Many patients experience symptoms of menopause such as hot flashes while taking this medication.
Ovarian Stimulation  Following ovarian suppression with Lupron, stimulation with gonadotropins (Fertinex) is begun. This medication is given in the form of a subcutaneous (under the skin) injection to stimulate the development of eggs within the ovary. Most patients are able to administer these injections themselves. During the stimulation phase (typically 10 to 12 days), the egg donor will come to our office for ultrasound monitoring of follicular (egg) development and blood testing for estrogen levels. When the follicles have achieved maturity, an injection of human chorionic gonadotropin (hCG) is given to trigger the final phase of maturation.
Egg Retrieval  The final phase of egg donation involves the extraction of eggs from the ovary. In this office-based procedure, the egg donor is given sedation with intravenous medications to make the procedure as comfortable as possible. Using vaginal ultrasound, a needle is directed through the vaginal wall into the ovary and the eggs are removed. The eggs are taken to the IVF laboratory where they are examined and fertilized with the recipient's husband's sperm. Most egg donors are able to return to work the day after the procedure. It is essential to take precautions to avoid pregnancy during the remainder of the cycle. A follow-up visit will be scheduled approximately one to two weeks after the egg retrieval.


Egg Donor Expectations: We recognize that your decision to participate in our program as an egg donor requires a great deal of work and inconvenience on your part. Accordingly, egg donors are reimbursed for their special efforts and inconvenience according to the following schedule. These reimbursements are subject to taxation and will be reported to the IRS as miscellaneous income on form 1099-M.

Schedule for reimbursements:

Lupron injections for ovarian suppression only
50.00
Injections for ovarian stimulation with ultrasounds and blood testing
100.00
Egg retrieval
1,750.00
Follow-up visit
100.00
Total:
$ 2,000.00

It is essential that you understand that failure to abide by the treatment protocol and maintain compliance with medications and the treatment schedule may result in cancellation of the treatment protocol. You must also recognize that it is important not to engage in any high-risk behavior which might result in an increased risk for sexually transmitted diseases.

If you have any questions after reading this information or need help completing your questionnaire, please do not hesitate to call. We look forward to talking more with you about this exciting treatment in the near future.